StonvexLoading…
StonvexStonvexStonvexCore line items from HXL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.89B | $1.90B | $1.79B | $1.58B |
Operating Income | $171.60M | $186.10M | $215.30M | $175.20M |
Net Income | $109.40M | $132.10M | $105.70M | $126.30M |
EPS (Diluted) | $1.37 | $1.59 | $1.24 | $1.49 |
Total Assets | $2.70B | $2.73B | $2.92B | $2.84B |
Total Liabilities | $1.45B | $1.20B | $1.20B | $1.28B |
Cash & Equivalents | $71.00M | $125.40M | $227.00M | $112.00M |
Free Cash Flow OCF − CapEx | $157.20M | $202.90M | $148.90M | $96.80M |
Shares Outstanding | 75.70M | 81.00M | 84.10M | 84.20M |